IE
LAB icon

Israel Englander’s Standard BioTools LAB Stock Holding History

Israel Englander’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-125,000
Closed -$490K – 7207
2021
Q4 		$490K Buy
125,000
+25,000
+25% +$117K ﹤0.01% 5061
2021
Q3 		$659K Buy
+100,000
New +$658K ﹤0.01% 5083
2016
Q1 		– Sell
-100,000
Closed -$1.08M – 3482
2015
Q4 		$1.08M Hold
100,000
– – ﹤0.01% 2266
2015
Q3 		$811K Buy
+100,000
New +$1.57M ﹤0.01% 2401

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Israel Englander's LAB Position: Q2 2026 in Review

Israel Englander increased its Standard BioTools (LAB) stake by 67% in Q2 2026, buying an estimated $1.33M and bringing the position to 3,512,665 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #3512.

Israel Englander first reported a position in LAB in Q2 2013 and has held it in 52 quarters since. The position peaked at $39M in Q1 2024. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Israel Englander held 3,512,665 shares of Standard BioTools worth $2.89M as of Q2 2026.
  • Israel Englander bought 1,410,650 Standard BioTools shares in Q2 2026, an estimated $1.33M.
  • Standard BioTools made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3512 holding.
  • Israel Englander first reported a position in Standard BioTools in Q2 2013 and has held it in 52 quarters since.
  • Israel Englander's Standard BioTools position peaked at $39M in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.